Logo image of LH

LABCORP HOLDINGS INC (LH) Stock Fundamental Analysis

USA - NYSE:LH - US5049221055 - Common Stock

266.89 USD
-0.98 (-0.37%)
Last: 11/14/2025, 8:04:00 PM
266.89 USD
0 (0%)
After Hours: 11/14/2025, 8:04:00 PM
Fundamental Rating

5

Overall LH gets a fundamental rating of 5 out of 10. We evaluated LH against 100 industry peers in the Health Care Providers & Services industry. LH has only an average score on both its financial health and profitability. LH is not valued too expensively and it also shows a decent growth rate.


Dividend Valuation Growth Profitability Health

6

1. Profitability

1.1 Basic Checks

In the past year LH was profitable.
LH had a positive operating cash flow in the past year.
LH had positive earnings in each of the past 5 years.
Each year in the past 5 years LH had a positive operating cash flow.
LH Yearly Net Income VS EBIT VS OCF VS FCFLH Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B

1.2 Ratios

LH has a better Return On Assets (4.68%) than 75.00% of its industry peers.
Looking at the Return On Equity, with a value of 9.83%, LH is in the better half of the industry, outperforming 71.00% of the companies in the same industry.
LH has a Return On Invested Capital of 6.32%. This is in the better half of the industry: LH outperforms 64.00% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for LH is below the industry average of 9.45%.
The last Return On Invested Capital (6.32%) for LH is above the 3 year average (6.31%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 4.68%
ROE 9.83%
ROIC 6.32%
ROA(3y)4.3%
ROA(5y)6.46%
ROE(3y)9.08%
ROE(5y)13.4%
ROIC(3y)6.31%
ROIC(5y)8.87%
LH Yearly ROA, ROE, ROICLH Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5 10 15 20

1.3 Margins

Looking at the Profit Margin, with a value of 6.21%, LH belongs to the top of the industry, outperforming 82.00% of the companies in the same industry.
LH's Profit Margin has declined in the last couple of years.
LH's Operating Margin of 9.92% is fine compared to the rest of the industry. LH outperforms 77.00% of its industry peers.
LH's Operating Margin has declined in the last couple of years.
LH has a Gross Margin (28.45%) which is in line with its industry peers.
LH's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 9.92%
PM (TTM) 6.21%
GM 28.45%
OM growth 3Y-27.95%
OM growth 5Y-7.41%
PM growth 3Y-31.82%
PM growth 5Y-4.26%
GM growth 3Y-9.83%
GM growth 5Y-0.21%
LH Yearly Profit, Operating, Gross MarginsLH Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10 20 30

5

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so LH is destroying value.
LH has less shares outstanding than it did 1 year ago.
The number of shares outstanding for LH has been reduced compared to 5 years ago.
LH has a worse debt/assets ratio than last year.
LH Yearly Shares OutstandingLH Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M
LH Yearly Total Debt VS Total AssetsLH Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5B 10B 15B 20B

2.2 Solvency

LH has an Altman-Z score of 3.16. This indicates that LH is financially healthy and has little risk of bankruptcy at the moment.
LH has a Altman-Z score of 3.16. This is in the better half of the industry: LH outperforms 67.00% of its industry peers.
LH has a debt to FCF ratio of 4.09. This is a neutral value as LH would need 4.09 years to pay back of all of its debts.
With a decent Debt to FCF ratio value of 4.09, LH is doing good in the industry, outperforming 71.00% of the companies in the same industry.
A Debt/Equity ratio of 0.59 indicates that LH is somewhat dependend on debt financing.
LH has a Debt to Equity ratio (0.59) which is comparable to the rest of the industry.
Industry RankSector Rank
Debt/Equity 0.59
Debt/FCF 4.09
Altman-Z 3.16
ROIC/WACC0.74
WACC8.53%
LH Yearly LT Debt VS Equity VS FCFLH Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B 8B 10B

2.3 Liquidity

LH has a Current Ratio of 1.55. This is a normal value and indicates that LH is financially healthy and should not expect problems in meeting its short term obligations.
LH's Current ratio of 1.55 is in line compared to the rest of the industry. LH outperforms 55.00% of its industry peers.
A Quick Ratio of 1.35 indicates that LH should not have too much problems paying its short term obligations.
Looking at the Quick ratio, with a value of 1.35, LH is in line with its industry, outperforming 50.00% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.55
Quick Ratio 1.35
LH Yearly Current Assets VS Current LiabilitesLH Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B 4B 5B

5

3. Growth

3.1 Past

The Earnings Per Share has grown by an nice 9.71% over the past year.
Measured over the past 5 years, LH shows a small growth in Earnings Per Share. The EPS has been growing by 5.20% on average per year.
LH shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 8.28%.
Measured over the past years, LH shows a small growth in Revenue. The Revenue has been growing by 2.40% on average per year.
EPS 1Y (TTM)9.71%
EPS 3Y-20.05%
EPS 5Y5.2%
EPS Q2Q%19.43%
Revenue 1Y (TTM)8.28%
Revenue growth 3Y-0.32%
Revenue growth 5Y2.4%
Sales Q2Q%8.58%

3.2 Future

LH is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 8.39% yearly.
The Revenue is expected to grow by 4.07% on average over the next years.
EPS Next Y15.41%
EPS Next 2Y11.3%
EPS Next 3Y10.56%
EPS Next 5Y8.39%
Revenue Next Year7.86%
Revenue Next 2Y6.15%
Revenue Next 3Y5.76%
Revenue Next 5Y4.07%

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
LH Yearly Revenue VS EstimatesLH Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 5B 10B 15B
LH Yearly EPS VS EstimatesLH Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 5 10 15 20 25

5

4. Valuation

4.1 Price/Earnings Ratio

LH is valuated correctly with a Price/Earnings ratio of 16.87.
Compared to the rest of the industry, the Price/Earnings ratio of LH indicates a somewhat cheap valuation: LH is cheaper than 77.00% of the companies listed in the same industry.
LH's Price/Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 25.89.
A Price/Forward Earnings ratio of 14.79 indicates a correct valuation of LH.
Based on the Price/Forward Earnings ratio, LH is valued a bit cheaper than 76.00% of the companies in the same industry.
LH is valuated cheaply when we compare the Price/Forward Earnings ratio to 34.59, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 16.87
Fwd PE 14.79
LH Price Earnings VS Forward Price EarningsLH Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

LH's Enterprise Value to EBITDA ratio is in line with the industry average.
72.00% of the companies in the same industry are more expensive than LH, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 16.06
EV/EBITDA 14.32
LH Per share dataLH EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 50 100 150

4.3 Compensation for Growth

LH's PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
LH has a very decent profitability rating, which may justify a higher PE ratio.
PEG (NY)1.09
PEG (5Y)3.25
EPS Next 2Y11.3%
EPS Next 3Y10.56%

5

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 1.17%, LH has a reasonable but not impressive dividend return.
Compared to an average industry Dividend Yield of 2.55, LH pays a better dividend. On top of this LH pays more dividend than 85.00% of the companies listed in the same industry.
With a Dividend Yield of 1.17, LH pays less dividend than the S&P500 average, which is at 2.36.
Industry RankSector Rank
Dividend Yield 1.17%

5.2 History

On average, the dividend of LH grows each year by 96.38%, which is quite nice.
LH has been paying a dividend for over 5 years, so it has already some track record.
The dividend of LH decreased in the last 3 years.
Dividend Growth(5Y)96.38%
Div Incr Years2
Div Non Decr Years2
LH Yearly Dividends per shareLH Yearly Dividends per shareYearly Dividends per share 2022 2023 2024 2025 1 2 3

5.3 Sustainability

28.24% of the earnings are spent on dividend by LH. This is a low number and sustainable payout ratio.
LH's earnings are growing slower than its dividend. This means the dividend growth is not sustainable.
DP28.24%
EPS Next 2Y11.3%
EPS Next 3Y10.56%
LH Yearly Income VS Free CF VS DividendLH Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B 2B 2.5B
LH Dividend Payout.LH Dividend Payout, showing the Payout Ratio.LH Dividend Payout.PayoutRetained Earnings

LABCORP HOLDINGS INC

NYSE:LH (11/14/2025, 8:04:00 PM)

After market: 266.89 0 (0%)

266.89

-0.98 (-0.37%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)10-28 2025-10-28/bmo
Earnings (Next)02-04 2026-02-04
Inst Owners100.29%
Inst Owner Change-0.21%
Ins Owners0.33%
Ins Owner Change-2.83%
Market Cap22.18B
Revenue(TTM)13.77B
Net Income(TTM)855.20M
Analysts83.45
Price Target307.03 (15.04%)
Short Float %2.95%
Short Ratio4.88
Dividend
Industry RankSector Rank
Dividend Yield 1.17%
Yearly Dividend2.91
Dividend Growth(5Y)96.38%
DP28.24%
Div Incr Years2
Div Non Decr Years2
Ex-Date11-26 2025-11-26 (0.72)
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-0.25%
Min EPS beat(2)-1.84%
Max EPS beat(2)1.34%
EPS beat(4)1
Avg EPS beat(4)-0.49%
Min EPS beat(4)-1.84%
Max EPS beat(4)1.34%
EPS beat(8)3
Avg EPS beat(8)-0.27%
EPS beat(12)4
Avg EPS beat(12)-0.63%
EPS beat(16)6
Avg EPS beat(16)0.3%
Revenue beat(2)0
Avg Revenue beat(2)-2.27%
Min Revenue beat(2)-2.8%
Max Revenue beat(2)-1.75%
Revenue beat(4)0
Avg Revenue beat(4)-2.81%
Min Revenue beat(4)-4.4%
Max Revenue beat(4)-1.75%
Revenue beat(8)0
Avg Revenue beat(8)-2.35%
Revenue beat(12)0
Avg Revenue beat(12)-5.86%
Revenue beat(16)0
Avg Revenue beat(16)-13.64%
PT rev (1m)2.12%
PT rev (3m)7.68%
EPS NQ rev (1m)-0.83%
EPS NQ rev (3m)-0.74%
EPS NY rev (1m)0.06%
EPS NY rev (3m)1.43%
Revenue NQ rev (1m)-0.14%
Revenue NQ rev (3m)-0.14%
Revenue NY rev (1m)-0.06%
Revenue NY rev (3m)0.06%
Valuation
Industry RankSector Rank
PE 16.87
Fwd PE 14.79
P/S 1.61
P/FCF 16.06
P/OCF 12.3
P/B 2.55
P/tB N/A
EV/EBITDA 14.32
EPS(TTM)15.82
EY5.93%
EPS(NY)18.05
Fwd EY6.76%
FCF(TTM)16.62
FCFY6.23%
OCF(TTM)21.7
OCFY8.13%
SpS165.65
BVpS104.66
TBVpS-18.73
PEG (NY)1.09
PEG (5Y)3.25
Graham Number193.01
Profitability
Industry RankSector Rank
ROA 4.68%
ROE 9.83%
ROCE 8.73%
ROIC 6.32%
ROICexc 6.57%
ROICexgc 20.66%
OM 9.92%
PM (TTM) 6.21%
GM 28.45%
FCFM 10.03%
ROA(3y)4.3%
ROA(5y)6.46%
ROE(3y)9.08%
ROE(5y)13.4%
ROIC(3y)6.31%
ROIC(5y)8.87%
ROICexc(3y)6.66%
ROICexc(5y)9.53%
ROICexgc(3y)24.5%
ROICexgc(5y)35.7%
ROCE(3y)8.72%
ROCE(5y)12.25%
ROICexgc growth 3Y-23.52%
ROICexgc growth 5Y-8.03%
ROICexc growth 3Y-23.85%
ROICexc growth 5Y-3.15%
OM growth 3Y-27.95%
OM growth 5Y-7.41%
PM growth 3Y-31.82%
PM growth 5Y-4.26%
GM growth 3Y-9.83%
GM growth 5Y-0.21%
F-Score9
Asset Turnover0.75
Health
Industry RankSector Rank
Debt/Equity 0.59
Debt/FCF 4.09
Debt/EBITDA 2.7
Cap/Depr 77.99%
Cap/Sales 3.07%
Interest Coverage 250
Cash Conversion 94.58%
Profit Quality 161.46%
Current Ratio 1.55
Quick Ratio 1.35
Altman-Z 3.16
F-Score9
WACC8.53%
ROIC/WACC0.74
Cap/Depr(3y)76.91%
Cap/Depr(5y)70.72%
Cap/Sales(3y)3.85%
Cap/Sales(5y)3.56%
Profit Quality(3y)157.09%
Profit Quality(5y)139.08%
High Growth Momentum
Growth
EPS 1Y (TTM)9.71%
EPS 3Y-20.05%
EPS 5Y5.2%
EPS Q2Q%19.43%
EPS Next Y15.41%
EPS Next 2Y11.3%
EPS Next 3Y10.56%
EPS Next 5Y8.39%
Revenue 1Y (TTM)8.28%
Revenue growth 3Y-0.32%
Revenue growth 5Y2.4%
Sales Q2Q%8.58%
Revenue Next Year7.86%
Revenue Next 2Y6.15%
Revenue Next 3Y5.76%
Revenue Next 5Y4.07%
EBIT growth 1Y20.09%
EBIT growth 3Y-28.19%
EBIT growth 5Y-5.19%
EBIT Next Year31.74%
EBIT Next 3Y14.33%
EBIT Next 5Y11.34%
FCF growth 1Y38.44%
FCF growth 3Y-25.49%
FCF growth 5Y0.97%
OCF growth 1Y28.67%
OCF growth 3Y-20.11%
OCF growth 5Y1.88%

LABCORP HOLDINGS INC / LH FAQ

Can you provide the ChartMill fundamental rating for LABCORP HOLDINGS INC?

ChartMill assigns a fundamental rating of 5 / 10 to LH.


What is the valuation status of LABCORP HOLDINGS INC (LH) stock?

ChartMill assigns a valuation rating of 5 / 10 to LABCORP HOLDINGS INC (LH). This can be considered as Fairly Valued.


What is the profitability of LH stock?

LABCORP HOLDINGS INC (LH) has a profitability rating of 6 / 10.


Can you provide the PE and PB ratios for LH stock?

The Price/Earnings (PE) ratio for LABCORP HOLDINGS INC (LH) is 16.87 and the Price/Book (PB) ratio is 2.55.


What is the financial health of LABCORP HOLDINGS INC (LH) stock?

The financial health rating of LABCORP HOLDINGS INC (LH) is 5 / 10.